John W. Bristol & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$86M Sell
351,933
-121,242
-26% -$28.2M 1.42% 33
2025
Q4
$97.9M Sell
473,175
-12,341
-3% -$2.44M 1.51% 28
2025
Q3
$90M Sell
485,516
-11,338
-2% -$1.94M 1.42% 31
2025
Q2
$75.9M Buy
496,854
+45
+0% +$6.92K 1.23% 38
2025
Q1
$82.4M Sell
496,809
-10,198
-2% -$1.6M 1.41% 32
2024
Q4
$73.3M Sell
507,007
-15,461
-3% -$2.4M 1.2% 37
2024
Q3
$84.7M Sell
522,468
-1,128,038
-68% -$180M 1.35% 36
2024
Q2
$241M Buy
1,650,506
+1,117,656
+210% +$166M 3.91% 5
2024
Q1
$84.3M Sell
532,850
-6,840
-1% -$1.09M 1.44% 34
2023
Q4
$84.6M Sell
539,690
-35,850
-6% -$5.5M 1.56% 35
2023
Q3
$89.6M Sell
575,540
-6,222
-1% -$1.03M 1.77% 30
2023
Q2
$96.3M Buy
581,762
+48,215
+9% +$7.78M 1.82% 29
2023
Q1
$82.7M Sell
533,547
-64,390
-11% -$10.4M 1.7% 31
2022
Q4
$106M Buy
597,937
+4,432
+0.7% +$765K 2.51% 13
2022
Q3
$97M Buy
593,505
+1,617
+0.3% +$274K 2.42% 18
2022
Q2
$105M Sell
591,888
-19,677
-3% -$3.51M 2.57% 14
2022
Q1
$108M Sell
611,565
-13,590
-2% -$2.31M 2.15% 22
2021
Q4
$107M Sell
625,155
-7,686
-1% -$1.26M 1.85% 26
2021
Q3
$102M Sell
632,841
-9,769
-2% -$1.67M 1.91% 24
2021
Q2
$106M Sell
642,610
-5,296
-0.8% -$877K 1.94% 23
2021
Q1
$106M Sell
647,906
-1,550
-0.2% -$251K 2.18% 21
2020
Q4
$102M Sell
649,456
-3,443
-0.5% -$508K 2.11% 23
2020
Q3
$97.2M Buy
652,899
+9,342
+1% +$1.38M 2.2% 21
2020
Q2
$90.5M Sell
643,557
-10,919
-2% -$1.59M 2.25% 23
2020
Q1
$85.8M Sell
654,476
-3,364
-0.5% -$477K 2.67% 16
2019
Q4
$96M Buy
657,840
+116,322
+21% +$15.8M 2.32% 15
2019
Q3
$70.1M Sell
541,518
-3,850
-0.7% -$507K 1.82% 26
2019
Q2
$76M Sell
545,368
-7,825
-1% -$1.08M 1.96% 25
2019
Q1
$77.3M Sell
553,193
-2,954
-0.5% -$396K 2.08% 24
2018
Q4
$71.8M Sell
556,147
-32,711
-6% -$4.56M 2.25% 20
2018
Q3
$81.4M Buy
588,858
+6,652
+1% +$884K 2.15% 19
2018
Q2
$70.6M Sell
582,206
-1,088,056
-65% -$136M 2% 25
2018
Q1
$214M Sell
1,670,262
-9,260
-0.6% -$1.25M 6.08% 1
2017
Q4
$235M Sell
1,679,522
-31,162
-2% -$4.34M 6.65% 1
2017
Q3
$222M Sell
1,710,684
-24,979
-1% -$3.31M 6.42% 1
2017
Q2
$230M Sell
1,735,663
-32,774
-2% -$4.18M 6.74% 1
2017
Q1
$220M Sell
1,768,437
-50,666
-3% -$6.05M 6.06% 1
2016
Q4
$210M Sell
1,819,103
-46,978
-3% -$5.43M 5.9% 1
2016
Q3
$220M Sell
1,866,081
-31,482
-2% -$3.82M 6.05% 1
2016
Q2
$230M Sell
1,897,563
-127,013
-6% -$14.4M 6.5% 1
2016
Q1
$219M Sell
2,024,576
-38,576
-2% -$3.99M 5.92% 1
2015
Q4
$212M Sell
2,063,152
-28,167
-1% -$2.83M 5.58% 1
2015
Q3
$195M Sell
2,091,319
-194,024
-8% -$18.8M 5.21% 1
2015
Q2
$223M Sell
2,285,343
-63,901
-3% -$6.4M 4.77% 1
2015
Q1
$236M Sell
2,349,244
-155,026
-6% -$15.8M 4.73% 1
2014
Q4
$262M Sell
2,504,270
-41,401
-2% -$4.36M 4.76% 1
2014
Q3
$271M Sell
2,545,671
-55,413
-2% -$5.75M 4.88% 1
2014
Q2
$272M Sell
2,601,084
-30,803
-1% -$3.11M 4.61% 1
2014
Q1
$259M Buy
2,631,887
+186,874
+8% +$17.3M 4.53% 1
2013
Q4
$224M Sell
2,445,013
-72,735
-3% -$6.7M 3.97% 1
2013
Q3
$218M Sell
2,517,748
-139,798
-5% -$12.5M 4.09% 1
2013
Q2
$228M Buy
+2,657,546
New +$226M 4.17% 1

Other funds holding JNJ

John W. Bristol & Co's JNJ Position: Q1 2026 in Review

John W. Bristol & Co reduced its Johnson & Johnson (JNJ) stake by 26% in Q1 2026, selling an estimated $28.2M and leaving 351,933 shares worth $86M. The position accounts for 1.42% of the portfolio, ranked #33.

John W. Bristol & Co first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $272M in Q2 2014. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • John W. Bristol & Co held 351,933 shares of Johnson & Johnson worth $86M as of Q1 2026.
  • John W. Bristol & Co sold 121,242 Johnson & Johnson shares in Q1 2026, an estimated $28.2M.
  • Johnson & Johnson made up 1.42% of John W. Bristol & Co's portfolio in Q1 2026, its #33 holding.
  • John W. Bristol & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • John W. Bristol & Co's Johnson & Johnson position peaked at $272M in Q2 2014.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on John W. Bristol & Co's 13F filing for Q1 2026, filed 14 May 2026.